TGFB2 and neoplasm: We further determined the expression of TGFβ2 and p‐ERK in the ESCC tumor xenografts and as shown in Figure S4B in the Supporting Information, the treatment of imperatorin led to the decrease of TGFβ2 expression and inactivation of ERK signaling in vivo.